| abstract |
The present invention generally relates to novel bispecific antigen binding molecules. Further, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, as well as vectors and host cells comprising the polynucleotides. The invention further relates to a process for the preparation of the bispecific antigen binding molecules of the invention and to the use of such bispecific antigen binding molecules in the treatment of diseases. |